ReP USP - Resultado da busca

Artigo de periodico
Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia (2024)
Marçal, Elisangela da Silva Rodrigues; Borges, Jéssica Bassani ; Bastos, Gisele Medeiros ; Hirata, Thiago Dominguez Crespo ; Oliveira, Victor Fernandes de ; Gonçalves, Rodrigo M ; Faludi, André Arpad; França, Joao Italo Dias ; Silva, Daiana Vitor de Oliveira; Malaquias, Vanessa Barbosa ; Luchessi, Andre Ducati ; Silbiger, Vivian Nogueira ; Nakazone, Marcelo Arruda ; Carmo, Tayanne Silva do ; Souza, Dorotéia Rossi Silva; Sampaio, Marcelo Ferraz; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: FCF, ICB
Subjects: HIPERCOLESTEROLEMIA, METILAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARÇAL, Elisangela da Silva Rodrigues et al. Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia. Epigenomics, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/17501911.2024.2351792. Acesso em: 18 nov. 2024.
APA
Marçal, E. da S. R., Borges, J. B., Bastos, G. M., Hirata, T. D. C., Oliveira, V. F. de, Gonçalves, R. M., et al. (2024). Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia. Epigenomics. doi:10.1080/17501911.2024.2351792
NLM
Marçal E da SR, Borges JB, Bastos GM, Hirata TDC, Oliveira VF de, Gonçalves RM, Faludi AA, França JID, Silva DV de O, Malaquias VB, Luchessi AD, Silbiger VN, Nakazone MA, Carmo TS do, Souza DRS, Sampaio MF, Hirata RDC, Hirata MH. Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia [Internet]. Epigenomics. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1080/17501911.2024.2351792
Vancouver
Marçal E da SR, Borges JB, Bastos GM, Hirata TDC, Oliveira VF de, Gonçalves RM, Faludi AA, França JID, Silva DV de O, Malaquias VB, Luchessi AD, Silbiger VN, Nakazone MA, Carmo TS do, Souza DRS, Sampaio MF, Hirata RDC, Hirata MH. Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia [Internet]. Epigenomics. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1080/17501911.2024.2351792
Artigo de periodico
Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity (2024)
Manriquez, Victor; Brito, Roberto; Pavez, Monica; Sapunar, Jorge; Fonseca, Luis; Molina, Víctor; Ortiz, Eugenia; Baeza, Romilio; Reimer, Camila; Charles, Maria; Schneider, Constance; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: international journal of obesity. Unidade: FCF
Subjects: ADENOVÍRUS, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANRIQUEZ, Victor et al. Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity. international journal of obesity, 2024Tradução . . Disponível em: https://dx.doi.org/10.1038/s41366-024-01555-x. Acesso em: 18 nov. 2024.
APA
Manriquez, V., Brito, R., Pavez, M., Sapunar, J., Fonseca, L., Molina, V., et al. (2024). Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity. international journal of obesity. doi:10.1038/s41366-024-01555-x
NLM
Manriquez V, Brito R, Pavez M, Sapunar J, Fonseca L, Molina V, Ortiz E, Baeza R, Reimer C, Charles M, Schneider C, Hirata MH, Hirata RDC, Cerda A. Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity [Internet]. international journal of obesity. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1038/s41366-024-01555-x
Vancouver
Manriquez V, Brito R, Pavez M, Sapunar J, Fonseca L, Molina V, Ortiz E, Baeza R, Reimer C, Charles M, Schneider C, Hirata MH, Hirata RDC, Cerda A. Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity [Internet]. international journal of obesity. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1038/s41366-024-01555-x
Artigo de periodico
Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study (2023)
Fajardo, Cristina Moreno ; Cerda, Alvaro ; Bortolin, Raul Hernandes ; Oliveira, Raquel de; Stefani, Tamires Invencioni Moraes; Santos, Marina Aparecida dos; Braga, Aécio Assunção; Dorea, Egídio Lima; Bernik, Marcia Martins Silveira; Bastos, Gisele Medeiros; Sampaio, Marcelo Ferraz; Damasceno, Nágila Raquel Teixeira; Verlengia, Rozangela; Oliveira, Maria Rita Marques de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Nutrition Research. Unidades: FCF, HU, FSP
Subjects: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno et al. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, v. 119, p. 21-32, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.nutres.2023.08.008. Acesso em: 18 nov. 2024.
APA
Fajardo, C. M., Cerda, A., Bortolin, R. H., Oliveira, R. de, Stefani, T. I. M., Santos, M. A. dos, et al. (2023). Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, 119, 21-32. doi:10.1016/j.nutres.2023.08.008
NLM
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Vancouver
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Artigo de periodico
Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients (2022)
Nascimento, Larissa Vilela ; Lotufo Neto, Francisco ; Moreira, Dalmo Antonio Ribeiro ; Cerutti, Virginia Braga; Thurow, Helena Strelow ; Bastos, Gisele Medeiros ; Ferreira, Eric Batista ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: FM, IDPC, FCF
Subjects: METILAÇÃO DE DNA, ANTIDEPRESSIVOS, ARRITMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Larissa Vilela et al. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients. Epigenomics, v. 14, n. 14, p. 851-864, 2022Tradução . . Disponível em: https://doi.org/10.2217/epi-2022-0089. Acesso em: 18 nov. 2024.
APA
Nascimento, L. V., Lotufo Neto, F., Moreira, D. A. R., Cerutti, V. B., Thurow, H. S., Bastos, G. M., et al. (2022). Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients. Epigenomics, 14( 14), 851-864. doi:10.2217/epi-2022-0089
NLM
Nascimento LV, Lotufo Neto F, Moreira DAR, Cerutti VB, Thurow HS, Bastos GM, Ferreira EB, Hirata RDC, Hirata MH. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients [Internet]. Epigenomics. 2022 ; 14( 14): 851-864.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2022-0089
Vancouver
Nascimento LV, Lotufo Neto F, Moreira DAR, Cerutti VB, Thurow HS, Bastos GM, Ferreira EB, Hirata RDC, Hirata MH. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients [Internet]. Epigenomics. 2022 ; 14( 14): 851-864.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2022-0089
Artigo de periodico
Association of occupational exposure to pesticides with overweight in farmers in Southern Brazil (2022)
Skonieskia, Calinca ; Fagundes, Karina Raquel ; Silva, Larissa da; Segat, Hecson Jesser ; Andrade, Anderson Joel Martino ; Bolzan, Rodrigo Cordeiro ; Hirata, Mario Hiroyuki ; Ferreira, Glaucio Monteiro ; Benvegnú, Dalila Moter
Source: Biomarkers. Unidade: FCF
Subjects: EXPOSIÇÃO OCUPACIONAL, PESTICIDAS, OBESIDADE, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SKONIESKIA, Calinca et al. Association of occupational exposure to pesticides with overweight in farmers in Southern Brazil. Biomarkers, v. 32, n. 12, p. 2798-2809, 2022Tradução . . Disponível em: https://dx.doi.org/10.1080/1354750X.2023.2268859. Acesso em: 18 nov. 2024.
APA
Skonieskia, C., Fagundes, K. R., Silva, L. da, Segat, H. J., Andrade, A. J. M., Bolzan, R. C., et al. (2022). Association of occupational exposure to pesticides with overweight in farmers in Southern Brazil. Biomarkers, 32( 12), 2798-2809. doi:10.1080/1354750X.2023.2268859
NLM
Skonieskia C, Fagundes KR, Silva L da, Segat HJ, Andrade AJM, Bolzan RC, Hirata MH, Ferreira GM, Benvegnú DM. Association of occupational exposure to pesticides with overweight in farmers in Southern Brazil [Internet]. Biomarkers. 2022 ; 32( 12): 2798-2809.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1080/1354750X.2023.2268859
Vancouver
Skonieskia C, Fagundes KR, Silva L da, Segat HJ, Andrade AJM, Bolzan RC, Hirata MH, Ferreira GM, Benvegnú DM. Association of occupational exposure to pesticides with overweight in farmers in Southern Brazil [Internet]. Biomarkers. 2022 ; 32( 12): 2798-2809.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1080/1354750X.2023.2268859
Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: IDPC, ICB, FCF
Subjects: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 18 nov. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer (2021)
Quintanilha, Julia C. F ; Cursino, Maria A; Borges, Jéssica Bassani; Torso, Nadine de Godoy ; Bastos, Larissa B; Oliveira, Juliana M; Cobaxo, Thiago S; Pincinato, Eder de Carvalho ; Hirata, Mario Hiroyuki ; Geraldo, Murilo Vieira ; Lima, Carmen S. P; Moriel, Patricia
Source: BMC Cancer. Unidade: FCF
Subjects: MICRORNAS, NEOPLASIAS DE CABEÇA E PESCOÇO, SEQUENCIAMENTO GENÉTICO, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUINTANILHA, Julia C. F et al. MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer. BMC Cancer, v. 21, p. 1-10 art. 575 , 2021Tradução . . Disponível em: https://doi.org/10.1186/s12885-021-08317-2. Acesso em: 18 nov. 2024.
APA
Quintanilha, J. C. F., Cursino, M. A., Borges, J. B., Torso, N. de G., Bastos, L. B., Oliveira, J. M., et al. (2021). MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer. BMC Cancer, 21, 1-10 art. 575 . doi:10.1186/s12885-021-08317-2
NLM
Quintanilha JCF, Cursino MA, Borges JB, Torso N de G, Bastos LB, Oliveira JM, Cobaxo TS, Pincinato E de C, Hirata MH, Geraldo MV, Lima CSP, Moriel P. MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer [Internet]. BMC Cancer. 2021 ; 21 1-10 art. 575 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12885-021-08317-2
Vancouver
Quintanilha JCF, Cursino MA, Borges JB, Torso N de G, Bastos LB, Oliveira JM, Cobaxo TS, Pincinato E de C, Hirata MH, Geraldo MV, Lima CSP, Moriel P. MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer [Internet]. BMC Cancer. 2021 ; 21 1-10 art. 575 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12885-021-08317-2
Artigo de periodico
Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum (2021)
Santos, Benedito Matheus dos ; Ferreira, Glaucio Monteiro ; Tavares, Maurício Temotheo ; Bona, Júlio César De ; Hirata, Mario Hiroyuki ; Paula, Vanderlúcia Fonseca de; Saturnino, Klaus Casaro ; Soares, Andreimar Martins ; Mendes, Mirian Machado
Source: Toxicon. Unidade: FCF
Subjects: VENENOS DE ORIGEM ANIMAL, ANTÍDOTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Benedito Matheus dos et al. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum. Toxicon, v. 193, p. 38–47, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.toxicon.2021.01.018. Acesso em: 18 nov. 2024.
APA
Santos, B. M. dos, Ferreira, G. M., Tavares, M. T., Bona, J. C. D., Hirata, M. H., Paula, V. F. de, et al. (2021). Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum. Toxicon, 193, 38–47. doi:10.1016/j.toxicon.2021.01.018
NLM
Santos BM dos, Ferreira GM, Tavares MT, Bona JCD, Hirata MH, Paula VF de, Saturnino KC, Soares AM, Mendes MM. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum [Internet]. Toxicon. 2021 ; 193 38–47.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.toxicon.2021.01.018
Vancouver
Santos BM dos, Ferreira GM, Tavares MT, Bona JCD, Hirata MH, Paula VF de, Saturnino KC, Soares AM, Mendes MM. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum [Internet]. Toxicon. 2021 ; 193 38–47.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.toxicon.2021.01.018
Artigo de periodico
Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Carolina Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M. ; Faludi, André A. ; Bastos, Gisele M. ; Jannes, Cinthia E. ; Pereira, Alexandre C. ; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, MICRORNAS, ENVELHECIMENTO, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 18 nov. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome (2021)
Braga, Aécio Assunção ; Bortolin, Raul Hernandes ; Saldarriaga, Magda Elizabeth Graciano ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, Hui Tzu Lin ; Borges, Jessica B; França, Joao Italo Dias ; Masi, Laureane Nunes ; Curi, Rui ; Curi, Tania Cristina Phiton ; Sampaio, Marcelo Ferraz; Castro, Lara R; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidade: FCF
Subjects: ADIPOSIDADE, SÍNDROME X METABÓLICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Aécio Assunção et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, v. 13, n. 6 p. 423–436, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0247. Acesso em: 18 nov. 2024.
APA
Braga, A. A., Bortolin, R. H., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2021). High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, 13( 6 p. 423–436). doi:10.2217/epi-2020-0247
NLM
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0247
Vancouver
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0247
Artigo de periodico
Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial (2021)
Cardoso, Thiago Augusto Azevedo Maranhão ; Kunst, Gudrun; Nigro Neto, Caetano; Costa Junior, José de Ribamar; Silva, Carlos Gustavo Santos; Bastos, Gisele Medeiros ; Borges, Jéssica Bassani ; Hirata, Mario Hiroyuki
Source: Trials. Unidades: IDPC, FCF
Subjects: CIRURGIA TORÁCICA, ÉTER, ANESTÉSICOS, CIRCULAÇÃO EXTRACORPÓREA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Thiago Augusto Azevedo Maranhão et al. Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial. Trials, v. 22, p. 1-10 art. 25, 2021Tradução . . Disponível em: https://doi.org/10.1186/s13063-020-04809-x. Acesso em: 18 nov. 2024.
APA
Cardoso, T. A. A. M., Kunst, G., Nigro Neto, C., Costa Junior, J. de R., Silva, C. G. S., Bastos, G. M., et al. (2021). Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial. Trials, 22, 1-10 art. 25. doi:10.1186/s13063-020-04809-x
NLM
Cardoso TAAM, Kunst G, Nigro Neto C, Costa Junior J de R, Silva CGS, Bastos GM, Borges JB, Hirata MH. Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial [Internet]. Trials. 2021 ; 22 1-10 art. 25.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s13063-020-04809-x
Vancouver
Cardoso TAAM, Kunst G, Nigro Neto C, Costa Junior J de R, Silva CGS, Bastos GM, Borges JB, Hirata MH. Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial [Internet]. Trials. 2021 ; 22 1-10 art. 25.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s13063-020-04809-x
Artigo de periodico
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study (2020)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Genvigir, Fabiana Dalla Vecchia ; Bonezi, Vivian; Hirata, Thiago Dominguez Crespo ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Epigenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, v. 12, n. 22, p. 2019-2034, 2020Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0160. Acesso em: 18 nov. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Genvigir, F. D. V., Bonezi, V., Hirata, T. D. C., Felipe, C. R., et al. (2020). Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, 12( 22), 2019-2034. doi:10.2217/epi-2020-0160
NLM
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0160
Vancouver
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0160
Artigo de periodico
Effect of preloading with high dose of rosuvastatin on serum levels of inflammatory markers after percutaneous coronary intervention (2020)
Slhessarenko, Juliano R; Hirata, Mario Hiroyuki ; Sousa, Amanda; Bastos, Gisele Medeiros ; Higa, Elisa M S; Mouro, Margareth G; Sobrera, Guilherme C; Slhessarenko, Renata D; Viana, Renata; Abizaid, Alexandre; Costa Junior, J. Ribamar
Source: Journal of Invasive Cardiology. Unidade: FCF
Subjects: ESTATINAS, HIPERPLASIAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SLHESSARENKO, Juliano R et al. Effect of preloading with high dose of rosuvastatin on serum levels of inflammatory markers after percutaneous coronary intervention. Journal of Invasive Cardiology, v. 32, n. 9, p. 335-341, 2020Tradução . . Disponível em: https://pubmed.ncbi.nlm.nih.gov/32568096. Acesso em: 18 nov. 2024.
APA
Slhessarenko, J. R., Hirata, M. H., Sousa, A., Bastos, G. M., Higa, E. M. S., Mouro, M. G., et al. (2020). Effect of preloading with high dose of rosuvastatin on serum levels of inflammatory markers after percutaneous coronary intervention. Journal of Invasive Cardiology, 32( 9), 335-341. Recuperado de https://pubmed.ncbi.nlm.nih.gov/32568096
NLM
Slhessarenko JR, Hirata MH, Sousa A, Bastos GM, Higa EMS, Mouro MG, Sobrera GC, Slhessarenko RD, Viana R, Abizaid A, Costa Junior JR. Effect of preloading with high dose of rosuvastatin on serum levels of inflammatory markers after percutaneous coronary intervention [Internet]. Journal of Invasive Cardiology. 2020 ; 32( 9): 335-341.[citado 2024 nov. 18 ] Available from: https://pubmed.ncbi.nlm.nih.gov/32568096
Vancouver
Slhessarenko JR, Hirata MH, Sousa A, Bastos GM, Higa EMS, Mouro MG, Sobrera GC, Slhessarenko RD, Viana R, Abizaid A, Costa Junior JR. Effect of preloading with high dose of rosuvastatin on serum levels of inflammatory markers after percutaneous coronary intervention [Internet]. Journal of Invasive Cardiology. 2020 ; 32( 9): 335-341.[citado 2024 nov. 18 ] Available from: https://pubmed.ncbi.nlm.nih.gov/32568096
Artigo de periodico
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy (2020)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Doi, Sonia de Quateli; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Herrero, María José; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, v. 21, n. 1, p. 7-21, 2020Tradução . . Disponível em: https://doi.org/10.2217/pgs-2019-0120. Acesso em: 18 nov. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. de Q., et al. (2020). CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, 21( 1), 7-21. doi:10.2217/pgs-2019-0120
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Artigo de periodico
The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial (2020)
Medeiros, Jeane Franco Pires; Borges, Michelle Vasconcelos de Oliveira; Soares, Aline Alves; Santos, Jessica Cavalcante dos; Oliveira, Ana Beatriz Bezerra de; Costa, Conceição Horrana Belo da; Cruz, Marina Sampaio; Bortolin, Raul Hernandes ; Freitas, Renata Caroline Costa de ; Dantas, Paulo Moreira Silva; Hirata, Mario Hiroyuki ; Silbiger, Vivian Nogueira; Luchessi, André Ducati
Source: Scientific Reports. Unidade: FCF
Subjects: VITAMINA D, SUPLEMENTAÇÃO ALIMENTAR, EXPRESSÃO GÊNICA, BIOLOGIA MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, Jeane Franco Pires et al. The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial. Scientific Reports, v. 10, p. 1-10 art. 11943, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-69128-2. Acesso em: 18 nov. 2024.
APA
Medeiros, J. F. P., Borges, M. V. de O., Soares, A. A., Santos, J. C. dos, Oliveira, A. B. B. de, Costa, C. H. B. da, et al. (2020). The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial. Scientific Reports, 10, 1-10 art. 11943. doi:10.1038/s41598-020-69128-2
NLM
Medeiros JFP, Borges MV de O, Soares AA, Santos JC dos, Oliveira ABB de, Costa CHB da, Cruz MS, Bortolin RH, Freitas RCC de, Dantas PMS, Hirata MH, Silbiger VN, Luchessi AD. The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial [Internet]. Scientific Reports. 2020 ; 10 1-10 art. 11943.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-020-69128-2
Vancouver
Medeiros JFP, Borges MV de O, Soares AA, Santos JC dos, Oliveira ABB de, Costa CHB da, Cruz MS, Bortolin RH, Freitas RCC de, Dantas PMS, Hirata MH, Silbiger VN, Luchessi AD. The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial [Internet]. Scientific Reports. 2020 ; 10 1-10 art. 11943.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-020-69128-2
Artigo de periodico
Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter (2020)
Arcas, Camila dos Santos; Wang, Hui Tzu Lin ; Umeda, Iracema Ioco Kikuchi; Sousa, Márcio Gonçalves; Utiyama, Daniela Mitiyo Odagiri; Mansur, Antonio de Padua ; Macchione, Mariangela ; Hirata, Mario Hiroyuki ; Nakagawa, Naomi Kondo
Source: Scientific Reports. Unidades: FM, FCF
Subjects: NEOPLASIAS NASOFARINGEAS, NEOPLASIAS PULMONARES, FUMANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCAS, Camila dos Santos et al. Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter. Scientific Reports, v. 10, p. 1-9 art. 21112, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-78242-0. Acesso em: 18 nov. 2024.
APA
Arcas, C. dos S., Wang, H. T. L., Umeda, I. I. K., Sousa, M. G., Utiyama, D. M. O., Mansur, A. de P., et al. (2020). Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter. Scientific Reports, 10, 1-9 art. 21112. doi:10.1038/s41598-020-78242-0
NLM
Arcas C dos S, Wang HTL, Umeda IIK, Sousa MG, Utiyama DMO, Mansur A de P, Macchione M, Hirata MH, Nakagawa NK. Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter [Internet]. Scientific Reports. 2020 ; 10 1-9 art. 21112.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-020-78242-0
Vancouver
Arcas C dos S, Wang HTL, Umeda IIK, Sousa MG, Utiyama DMO, Mansur A de P, Macchione M, Hirata MH, Nakagawa NK. Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter [Internet]. Scientific Reports. 2020 ; 10 1-9 art. 21112.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-020-78242-0
Artigo de periodico
TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease (2019)
Duarte, Victor Hugo Rezende ; Miranda, Carolinne Tháısa de Oliveira Fernandes ; Cruz, Marina Sampaio; Araujo, Jessica Nayara Goes de; Duarte, Mychelle Kytchia Rodrigues Nunes; Santos, Ayda Maria Quirino Silva dos; Santos, Isabelle Cristina Clemente dos; Santos, Jéssica Cavalcante dos; Silva, Ananília Medeiros Gomes da; Oliveira, Juliana Marinho de; Paiva, Maria Sanali Moura de Oliveira; Galvão, Marcos Felipe de Oliveira ; Rezende, Adriana Augusto ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Source: Scientific Reports. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, POLIMORFISMO, LEUCÓCITOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Victor Hugo Rezende et al. TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease. Scientific Reports, v. 9, p. 1-8 art. 7229, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-43745-y. Acesso em: 18 nov. 2024.
APA
Duarte, V. H. R., Miranda, C. T. de O. F., Cruz, M. S., Araujo, J. N. G. de, Duarte, M. K. R. N., Santos, A. M. Q. S. dos, et al. (2019). TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease. Scientific Reports, 9, 1-8 art. 7229. doi:10.1038/s41598-019-43745-y
NLM
Duarte VHR, Miranda CT de OF, Cruz MS, Araujo JNG de, Duarte MKRN, Santos AMQS dos, Santos ICC dos, Santos JC dos, Silva AMG da, Oliveira JM de, Paiva MSM de O, Galvão MF de O, Rezende AA, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease [Internet]. Scientific Reports. 2019 ; 9 1-8 art. 7229.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-019-43745-y
Vancouver
Duarte VHR, Miranda CT de OF, Cruz MS, Araujo JNG de, Duarte MKRN, Santos AMQS dos, Santos ICC dos, Santos JC dos, Silva AMG da, Oliveira JM de, Paiva MSM de O, Galvão MF de O, Rezende AA, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease [Internet]. Scientific Reports. 2019 ; 9 1-8 art. 7229.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-019-43745-y
Artigo de periodico
Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis (2017)
Nascimento, Ivan Pereira; Rodriguez, Dúnia; Santos, Carina Carvalho dos; Amaral, Eduardo Pinheiro; Rofatto, Henrique Krambeck; Junqueira-Kipnis, Ana Paula; Gonçalves, Eduardo Dantas Casillo; Lima, Maria Regina D'Império ; Hirata, Mario Hiroyuki ; Silva, Célio Lopes; Winter, Nathalie; Gicquel, Brigitte; Mills, Kingston H G; Pizza, Mariagrazia; Rappuoli, Rino; Leite, Luciana C. C
Source: Scientific Reports. Unidades: ICB, FCF, FMRP
Subjects: IMUNOLOGIA, TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS, ADJUVANTES IMUNOLÓGICOS, PROTEÍNAS RECOMBINANTES, VACINAS, CITOCININAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Ivan Pereira et al. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, v. 7, n. 1, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-02003-9. Acesso em: 18 nov. 2024.
APA
Nascimento, I. P., Rodriguez, D., Santos, C. C. dos, Amaral, E. P., Rofatto, H. K., Junqueira-Kipnis, A. P., et al. (2017). Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, 7( 1), 1-11. doi:10.1038/s41598-017-02003-9
NLM
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Vancouver
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Artigo de periodico
Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats (2017)
Ferreira, Elaine C. S; Bortolin, Raul H; Freire-Neto, Francisco Paulo; Souza, Karla S. C; Bezerra, João F; Ururahy, Marcela Abbott Galvão; Ramos, Ana M. O; Himelfarb, Silvia Tchernin; Abreu, Bento J; Didone, Thiago Vinicios Nadaleto; Pedrosa, Lucia F. C; Medeiros, Aldo C; Doi, Sonia Q; Brandão Neto, José; Hirata, Rosario Dominguez Crespo ; Rezende, Luciana A; Almeida, Maria G; Hirata, Mario Hiroyuki ; Rezende, Adriana A
Source: Nutrition Research. Unidade: FCF
Subjects: ZINCO, ESTRÓGENOS, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elaine C. S et al. Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats. Nutrition Research, v. 40, p. 48-56, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.nutres.2017.03.004. Acesso em: 18 nov. 2024.
APA
Ferreira, E. C. S., Bortolin, R. H., Freire-Neto, F. P., Souza, K. S. C., Bezerra, J. F., Ururahy, M. A. G., et al. (2017). Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats. Nutrition Research, 40, 48-56. doi:10.1016/j.nutres.2017.03.004
NLM
Ferreira ECS, Bortolin RH, Freire-Neto FP, Souza KSC, Bezerra JF, Ururahy MAG, Ramos AMO, Himelfarb ST, Abreu BJ, Didone TVN, Pedrosa LFC, Medeiros AC, Doi SQ, Brandão Neto J, Hirata RDC, Rezende LA, Almeida MG, Hirata MH, Rezende AA. Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats [Internet]. Nutrition Research. 2017 ; 40 48-56.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.nutres.2017.03.004
Vancouver
Ferreira ECS, Bortolin RH, Freire-Neto FP, Souza KSC, Bezerra JF, Ururahy MAG, Ramos AMO, Himelfarb ST, Abreu BJ, Didone TVN, Pedrosa LFC, Medeiros AC, Doi SQ, Brandão Neto J, Hirata RDC, Rezende LA, Almeida MG, Hirata MH, Rezende AA. Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats [Internet]. Nutrition Research. 2017 ; 40 48-56.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.nutres.2017.03.004
Artigo de periodico
Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients (2017)
Guimarães, Elizandra Silva; Cerda, Alvaro; Dórea, Egídio Lima; Bernik, Marcia Martins Silveira; Gusukuma, Maria Cecília; Pinto, Gelba Almeida; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Cardiovascular Therapeutics. Unidades: HU, FCF
Subjects: DISLIPIDEMIAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Elizandra Silva et al. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular Therapeutics, v. 35, n. 6, p. art. e12307 1-8, 2017Tradução . . Disponível em: https://doi.org/10.1111/1755-5922.12307. Acesso em: 18 nov. 2024.
APA
Guimarães, E. S., Cerda, A., Dórea, E. L., Bernik, M. M. S., Gusukuma, M. C., Pinto, G. A., et al. (2017). Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular Therapeutics, 35( 6), art. e12307 1-8. doi:10.1111/1755-5922.12307
NLM
Guimarães ES, Cerda A, Dórea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 6): art. e12307 1-8.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/1755-5922.12307
Vancouver
Guimarães ES, Cerda A, Dórea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 6): art. e12307 1-8.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/1755-5922.12307

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration